Recently, we have discovered that mGluR1 is expressed and active in breast cancer cells and that Riluzole, at doses equivalent to doses already being used clinically in humans to treat ALS, can significantly inhibit the growth of breast tumor xenografts [38]. The gene discussed is GRM1; the disease is breast neoplasm.